Tolvaptan is a medicine used to help slow the progression of autosomal dominant polycystic kidney disease (ADPKD), an inherited condition that causes fluid-filled cysts to develop in the kidneys. This page provides information on the safe use, monitoring and ongoing management of tolvaptan treatment.
Precocious puberty is a condition in which puberty starts earlier than expected. This page provides information on the use and management of triptorelin treatment to help delay the progression of puberty where clinically appropriate.
Valproate is used in the treatment of epilepsy and certain mental health conditions but is associated with significant risks during pregnancy and following exposure at conception. This page provides information to support the safe use of valproate, including compliance with national safety requirements, pregnancy prevention measures and prescribing considerations for patients of childbearing potential.
Wound care and tissue viability guidance supports the effective assessment and management of wounds. This page provides clinical guidance, pathways and formularies relating to wound care, dressings and tissue viability.
